IQV
IQVIA Holdings IncNYSEHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$28.19B
P/E Ratio
21.16
EPS
$7.85
Beta
1.41
52W High
$247.05
52W Low
$134.65
50-Day MA
$194.23
200-Day MA
$195.59
Dividend Yield
—
Profit Margin
8.34%
Forward P/E
13.21
PEG Ratio
0.98
About IQVIA Holdings Inc
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.
Fundamentals
| Revenue (TTM) | $16.31B |
| Gross Profit (TTM) | $5.43B |
| EBITDA | $2.94B |
| Operating Margin | 15.20% |
| Return on Equity | 21.40% |
| Return on Assets | 5.05% |
| Revenue/Share (TTM) | $94.88 |
| Book Value | $38.34 |
| Price-to-Book | 4.31 |
| Price-to-Sales (TTM) | 1.73 |
| EV/Revenue | 2.565 |
| EV/EBITDA | 12.08 |
| Quarterly Earnings Growth (YoY) | 23.60% |
| Quarterly Revenue Growth (YoY) | 10.30% |
| Shares Outstanding | $167.87M |
| Float | $161.25M |
| % Insiders | 1.09% |
| % Institutions | 103.32% |
Historical Volatility
HV 10-Day
30.50%
HV 20-Day
41.20%
HV 30-Day
43.11%
HV 60-Day
49.38%
HV Rank
59.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($236.19 target)
3
Strong Buy16
Buy5
HoldData last updated: 3/25/2026